Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations
These consensus recommendations are intended to increase awareness of potential cardiovascular/cardiometabolic risks in patients with narcolepsy for all clinicians. Early monitoring for, and prevention of, cardiovascular risks in this population are of great importance, especially as narcolepsy usually develops in adolescents and young adults, who will be exposed to adverse effects of the disease for decades. Prospective systematic studies are needed to determine association and causation of narcolepsy with cardiovascular/cardiometabolic disorders.
Authors
- Thomas E. Scammell (ORCID: https://orcid.org/0000-0002-7231-8558)
- Younghoon Kwon (ORCID: https://orcid.org/0000-0002-8152-9170)
- Gregg S. Pressman (ORCID: https://orcid.org/0000-0002-0992-1805)
- Lee A. Surkin (ORCID: https://orcid.org/0000-0002-8905-1167)
- Phyllis C. Zee (ORCID: https://orcid.org/0000-0001-6296-6685)
- Shahrokh Javaheri
- Apoor S. Gami
Institutions
- Northwestern University (US)
- Beth Israel Deaconess Medical Center (US)
- University of Washington (US)
- Bethesda North Hospital (US)
- Circadian (United States) (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1161/jaha.124.035168
- Citations
- 11
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 3.77
Funders
- U.S. Department of Defense
- Eli Lilly and Company
- Harmony Biosciences
- ResMed
- National Institutes of Health